Xconomy: Five Biotechnologies That Will Fade Away This Decade
Summary
Prepare to live in a world where the platform owners and database organizers have a greater proportion of the value proposition.VCs would be smart to invest in platforms and those who can offer up access to the evolving models of disease from which will spring the dynamic biomarkers.The old methods used for these studies assumed that the analysis would be done by the small group of primary collectors of the samples and data.This model, too, will be fading as distributed groups of scientists evolve the knowledge faster and more efficiently than those who generated the data.This means biologists will need to start pooling their knowledge through social networking channels, not unlike how computer scientists have long done for open source software development.
Classifications
AskAI Classifications
LabelsLinked Companies
